WHO Endorses GLP-1 Drugs for Obesity: Global Guidelines for Long-Term Care
#health #obesity #glp1 #who #guidelines
WHO endorses GLP-1 therapies for obesity, emphasizing long-term use with lifestyle interventions.
Latest right now for #glp1
GLP-1 Drugs Reshape US Consumer Spending
#glp1 #consumer_spending #healthcare #business
GLP-1 medications like Ozempic and Wegovy are changing how Americans spend, influencing groceries, dining, and apparel.
Wegovy Pill Approved by US FDA for Weight Loss and CV Risk Reduction
#wegovy #weight_management #fda #glp1 #pharmaceuticals
The FDA approves Wegovy as the first oral GLP-1 therapy for long-term weight management and cardiovascular risk reduction.
